Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Schneyer Mark C. sold 20,141 Acadia Pharmaceuticals Inc. shares (Form 4)
Traded Aug 5 to Aug 6, 2026 · Filed Aug 7, 2026
From Aug 5 to Aug 6, 2026, Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 20,141 Acadia Pharmaceuticals Inc. shares at an average US$29.16 for US$587K under a trading plan, leaving 67,828 shares. Filed Aug 7, 2026 (Form 4).
- Sold
- 20,141 shares
- Price
- US$29.16 average (US$29.00 to US$29.34)
- Value
- US$587K
- Holding after
- 67,828 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | Option exercise | 5,849 | US$17.84 | 73,677 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 5,849 | US$29.00 | 67,828 | Direct |
| Aug 6, 2026 | Common Stock | Option exercise | 14,292 | US$17.84 | 82,120 | Direct |
| Aug 6, 2026 | Common Stock | Sale | 5,000 | US$29.00 | 77,120 | Direct |
| Aug 6, 2026 | Common Stock | Sale | 9,292 | US$29.34 | 67,828 | Direct |
Source
Related
- Acadia Pharmaceuticals Inc.
- Schneyer Mark C.
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · May 5, 2026
- Form 4 · Schneyer Mark C. · Apr 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026
- Form 4 · Harrigan Edmund · Jun 1, 2026